HUP0003249A2 - Eljárás izolált szisztolás hipertenzió kezelésére eprosartannal - Google Patents

Eljárás izolált szisztolás hipertenzió kezelésére eprosartannal

Info

Publication number
HUP0003249A2
HUP0003249A2 HU0003249A HUP0003249A HUP0003249A2 HU P0003249 A2 HUP0003249 A2 HU P0003249A2 HU 0003249 A HU0003249 A HU 0003249A HU P0003249 A HUP0003249 A HU P0003249A HU P0003249 A2 HUP0003249 A2 HU P0003249A2
Authority
HU
Hungary
Prior art keywords
eprosartan
systolic hypertension
isolated systolic
treating isolated
treating
Prior art date
Application number
HU0003249A
Other languages
English (en)
Inventor
David P. Brooks
Giora Z. Feuerstein
Eliot H. Ohlstein
Robert R. Ruffolo
Original Assignee
Smithkline Beecham Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp. filed Critical Smithkline Beecham Corp.
Publication of HUP0003249A2 publication Critical patent/HUP0003249A2/hu
Publication of HUP0003249A3 publication Critical patent/HUP0003249A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Fixed Capacitors And Capacitor Manufacturing Machines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

A találmány az eprosartan, azaz az (E)-2-{[2-butil-l-(4-karboxi-benzil)-1H-5-imidazolil]-metilén}-3-(2-tienil)-propionsav-monometánszulfonát izolált szisztolés hipertenzió kezelésére történőalkalmazására vonatkozik. Ó
HU0003249A 1997-05-27 1998-05-27 Method of treating isolated systolic hypertension using eprosartan HUP0003249A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4780097P 1997-05-27 1997-05-27
PCT/US1998/010794 WO1998053816A1 (en) 1997-05-27 1998-05-27 Method of treating isolated systolic hypertension

Publications (2)

Publication Number Publication Date
HUP0003249A2 true HUP0003249A2 (hu) 2002-01-28
HUP0003249A3 HUP0003249A3 (en) 2002-02-28

Family

ID=21951046

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003249A HUP0003249A3 (en) 1997-05-27 1998-05-27 Method of treating isolated systolic hypertension using eprosartan

Country Status (24)

Country Link
US (1) US20020040045A1 (hu)
EP (1) EP1003506B1 (hu)
JP (1) JP2002500673A (hu)
KR (1) KR20010013014A (hu)
CN (1) CN1257427A (hu)
AR (1) AR012872A1 (hu)
AT (1) ATE307580T1 (hu)
AU (1) AU740646B2 (hu)
BR (1) BR9809611A (hu)
CA (1) CA2288722C (hu)
CZ (1) CZ298390B6 (hu)
DE (1) DE69832075T2 (hu)
ES (1) ES2251083T3 (hu)
HU (1) HUP0003249A3 (hu)
IL (1) IL132154A (hu)
MX (1) MXPA99010970A (hu)
NO (1) NO326141B1 (hu)
NZ (1) NZ337888A (hu)
PL (1) PL191971B1 (hu)
SA (1) SA98190174B1 (hu)
TR (1) TR199902914T2 (hu)
TW (1) TW579296B (hu)
WO (1) WO1998053816A1 (hu)
ZA (1) ZA984421B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006076097A2 (en) * 2004-12-07 2006-07-20 Nektar Therapeutics Stable non-crystalline formulation comprising losartan

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US544080A (en) * 1895-08-06 Centrifugal filtering-machine
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
US5418250A (en) * 1989-06-14 1995-05-23 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
JPH05199342A (ja) * 1991-05-20 1993-08-06 Xerox Corp 無声の手書きによる携帯式通信装置および方法

Also Published As

Publication number Publication date
EP1003506B1 (en) 2005-10-26
AU7601798A (en) 1998-12-30
IL132154A (en) 2002-12-01
DE69832075D1 (de) 2005-12-01
CZ420099A3 (cs) 2000-09-13
JP2002500673A (ja) 2002-01-08
AU740646B2 (en) 2001-11-08
IL132154A0 (en) 2001-03-19
TW579296B (en) 2004-03-11
EP1003506A1 (en) 2000-05-31
SA98190174B1 (ar) 2006-05-13
CA2288722A1 (en) 1998-12-03
WO1998053816A1 (en) 1998-12-03
EP1003506A4 (en) 2000-11-29
CZ298390B6 (cs) 2007-09-19
KR20010013014A (ko) 2001-02-26
CA2288722C (en) 2007-04-24
NO995797D0 (no) 1999-11-26
PL336886A1 (en) 2000-07-17
DE69832075T2 (de) 2006-07-13
BR9809611A (pt) 2000-07-04
CN1257427A (zh) 2000-06-21
TR199902914T2 (xx) 2000-06-21
NZ337888A (en) 2001-04-27
NO326141B1 (no) 2008-10-06
NO995797L (no) 1999-11-26
ZA984421B (en) 1998-11-27
ES2251083T3 (es) 2006-04-16
ATE307580T1 (de) 2005-11-15
US20020040045A1 (en) 2002-04-04
AR012872A1 (es) 2000-11-22
HUP0003249A3 (en) 2002-02-28
MXPA99010970A (es) 2005-07-25
PL191971B1 (pl) 2006-07-31

Similar Documents

Publication Publication Date Title
DE60032783D1 (en) Thrombopoietinmimetika
NO20021281D0 (no) Vaskul¶r beleggingssammensetning
ATE202140T1 (de) Hemmung der neovaskulasierung durch vegf- spezifische oligonukleotide
ZA981936B (en) Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
MXPA05006359A (es) Tratamiento de la enfermedad a traves de inhibidores peptidos antimicrobianos.
YU17402A (sh) Nova spiroheterociklična jedinjenja upotrebljiva kao reverzibilni inhibitori cisteinskih proteaza
WO2002044156A3 (en) Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
HUP9802556A1 (hu) Eljárás és készítmény kötőszöveti kapcsolódások gyógyítására és helyreállítására
WO2002080858A3 (en) Use of kpv tripeptide for dermatological disorders
EP1244446A4 (en) Thrombopoietin mimetics
CA2250395A1 (en) Eprosartan dihydrate and a process for its production and formulation
DE60019321D1 (de) Verfahren zum screening von inhibitoren von asp2
NZ332096A (en) Alpha-hydroxylic acid derivatives their production and use in treating conditions requiring endothelin inhibition
WO2002036580A3 (en) Benzoxazole lpaat- beta inhibitors and uses thereof
DE69611452D1 (de) Benzothiophenderivate
CY1105851T1 (el) Εξουδετερωσις-φορτιο-συμπλοκου επροσαρταν-αργινυλιου και μεθοδος δια την παραγωγη του και διαμορφωσις
ATE402257T1 (de) Antisense gegen c-myc zur behandlung von polyzystischer nierenkrankheit
HUP0003249A2 (hu) Eljárás izolált szisztolás hipertenzió kezelésére eprosartannal
WO2003000183A3 (en) Method of treating atherosclerosis and other inflammatory diseases
AU7736896A (en) Methods to prevent and treat acid mine drainage and to remove metals and non-metals from aqueous sources
AU3934000A (en) Inhibitors of endothelin-1 synthesis
MY120085A (en) Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines.
DE60130524D1 (de) Verfahren zur elektrochemischen Behandlung von Artikeln
HUP0100105A2 (hu) TNF-antagonisták alkalmazása szeptikus betegségek kezelésére szolgáló gyógyszerként
NO20004393D0 (no) Anvendelse av CD137 for Õ fremme proliferering av perifere monocytter

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees